New diabetes drug candidate tested in healthy men for safety
NCT ID NCT06284798
First seen Dec 11, 2025 · Last updated May 16, 2026 · Updated 19 times
Summary
This early-stage study tested a new medicine called NNC0650-0013, which may one day treat type 2 diabetes, in 11 healthy men. The main goal was to check safety and how the drug moves through the body. Participants received a single injection of the drug or a placebo. The study lasted 11 to 17 weeks and required three overnight fasts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.